Therapeutics: BCL2/adenovirus E1B 19kDa interacting protein 3 (BNIP3)

Cardiovascular disease

INDICATION: Organ damage

In vitro and mouse studies suggest BNIP3 antagonists could

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE